Silverarc Capital Management »

Kymera Therapeutics shares owned by Silverarc Capital Management

Quarter-by-quarter ownership of Kymera Therapeutics shares owned by Silverarc Capital Management from 13F filings

Historical chart of Silverarc Capital Management investment in Kymera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kymera Therapeutics held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kymera Therapeutics by Silverarc Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.9M 25k 114.67

More positions owned by Silverarc Capital Management

Ascendis Pharma A/s Ord Shs (ASND)
Celcuity (CELC)
Cogent Biosciences (COGT)
Urogen Pharma (URGN)
Immunome (IMNM)
Dianthus Therapeutics (DNTH)
Rhythm Pharmaceuticals (RYTM)
Oruka Therapeutics (ORKA)
Monte Rosa Therapeutics (GLUE)
Syndax Pharmaceuticals (SNDX)
Enliven Therapeutics (ELVN)
Immunovant (IMVT)
Erasca (ERAS)
Sagimet Biosciences Com Ser A (SGMT)
Abivax Sa Sponsored Ads (ABVX)

View all positions for Silverarc Capital Management

Top funds holding Kymera Therapeutics

Silverarc Capital Management
Simplex Trading

View all funds holding Kymera Therapeutics